CHPA submits these comments on the proposal published by the Food and Drug Administration in 64 Fed. Reg. 66822 (November 30, 1999) to revise its citizen petition regulations, 21 C.F.R. § 10.25 and 21 C.F.R. § 10.30.
Request for agency exercise of enforcement discretion regarding the addition of new Warning language to Drug Facts labeling for Over-the-Counter benzocaine liquid/gel products indicated for relieving oral discomfort.
If you have a flexible spending arrangement (FSA) or health savings account (HSA) you can now use these pre-tax savings for purchasing over-the-counter medicines.
CHPA supports a review of existing rules and coordination efforts to identify opportunities that could mitigate shortage risks during times of peak need.
Learn about CHPA's current slate of federal legislative priorities including OTC regulatory reform, dietary supplement regulation modernization, supply chain and product integrity, and more.
Millions of Americans rely on OTC medicines as an accessible and effective solution for commonly occurring conditions. Learn about the value that OTCs provide to the U.S. healthcare system.
